Clinical Trials
3 trialsNCT00199836 2022-10-10
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and MontanideĀ® ISA-51 in Patients With Cancer.
Ludwig Institute for Cancer Research
Phase 1 Completed
NCT00471471 2017-06-22
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
University of Pittsburgh
Phase 1 Completed
NCT00233506 2017-02-06
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
University of Iowa
Phase 1 Completed